These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9089333

  • 1. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2.
    Guarna A, Belle C, Machetti F, Occhiato EG, Payne AH, Cassiani C, Comerci A, Danza G, De Bellis A, Dini S, Marrucci A, Serio M.
    J Med Chem; 1997 Mar 28; 40(7):1112-29. PubMed ID: 9089333
    [Abstract] [Full Text] [Related]

  • 2. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of human steroid 5alpha reductases type I and II by 6-aza-steroids: structural determinants of one-step vs two-step mechanism.
    Moss ML, Kuzmic P, Stuart JD, Tian G, Peranteau AG, Frye SV, Kadwell SH, Kost TA, Overton LK, Patel IR.
    Biochemistry; 1996 Mar 19; 35(11):3457-64. PubMed ID: 8639496
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
    Kadohama N, Karr JP, Murphy GP, Sandberg AA.
    Cancer Res; 1984 Nov 01; 44(11):4947-54. PubMed ID: 6488158
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S, Schnabel D, Feix M, Wolf L, Schaefer HE, Russell DW, Schweikert HU.
    J Clin Endocrinol Metab; 2002 Dec 01; 87(12):5401-7. PubMed ID: 12466325
    [Abstract] [Full Text] [Related]

  • 11. Different patterns of 5alpha-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells.
    Liu S, Yamauchi H.
    Biochem Biophys Res Commun; 2008 Apr 18; 368(4):858-64. PubMed ID: 18258185
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
    Pérez-Ornelas V, Cabeza M, Bratoeff E, Heuze I, Sánchez M, Ramírez E, Naranjo-Rodríguez E.
    Steroids; 2005 Mar 18; 70(3):217-24. PubMed ID: 15763601
    [Abstract] [Full Text] [Related]

  • 14. Benzo[c]quinolizin-3-ones: a novel class of potent and selective nonsteroidal inhibitors of human steroid 5alpha-reductase 1.
    Guarna A, Machetti F, Occhiato EG, Scarpi D, Comerci A, Danza G, Mancina R, Serio M, Hardy K.
    J Med Chem; 2000 Oct 05; 43(20):3718-35. PubMed ID: 11020287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN, Douglas RC, Vessey JP, Gupta R, Fontaine D, Norman RW, Thompson IM, Troyer DA, Rittmaster RS, Lazier CB.
    J Urol; 2003 Nov 05; 170(5):2019-25. PubMed ID: 14532845
    [Abstract] [Full Text] [Related]

  • 18. Actions of 5alpha-reductase inhibitors on the epididymis.
    Robaire B, Henderson NA.
    Mol Cell Endocrinol; 2006 May 16; 250(1-2):190-5. PubMed ID: 16476520
    [Abstract] [Full Text] [Related]

  • 19. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J, Altwein J.
    Prostate Cancer Prostatic Dis; 2009 May 16; 12(2):130-6. PubMed ID: 19030020
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.